Watch Ticker

Pharvaris N.V. Ordinary Shares

Go to Pharvaris N.V. Ordinary Shares Website

$21.00

-0.23 (-1.11%)

Live

Previous Close

$21

Day Range

$20.755 - $22.3

Previous Day Range

$20.03 - $21.8

Market Cap

$1.4 billion USD

Day Vol.

117893

Previous Day Vol.

165357

Currency

USD

Primary Exchange

Nasdaq

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules,...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Pharvaris N.V. - Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Pharvaris, a biopharmaceutical company, has priced a public offering of 8,250,000 ordinary shares at $20.00 per share and pre-funded warrants to purchase 500,000 shares, expecting to raise approximately $175 million.

Related tickers: PHVS, MS, MSpA, MSpE, MSpF, MSpI, MSpK, MSpL, MSpO, MSpP, MSpQ.

Read Full Article

Pharvaris - Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress

Pharvaris presented data at the EAACI Congress 2025 supporting the potential of its oral bradykinin B2 receptor antagonist, deucrictibant, for the prophylactic and on-demand treatment of bradykinin-mediated angioedema attacks.

Related tickers: PHVS.

Read Full Article

Trending Tickers

Please sign in to view